Jbf Capital, Inc. Sio Gene Therapies Inc. Transaction History

Jbf Capital, Inc.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2023 May 12, 2023	BUY	$0.4 - $0.46 $883,810 - $1.02 Million	2,209,527 Added 514.32%	2,639,127 $1.06 Million
Q4 2022 Feb 08, 2023	BUY	$0.28 - $0.44 $120,288 - $189,024	429,600 New	429,600 $189,000

147K

Ticker SIOX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,975,200
Description
Sio Gene Therapies Inc., a clinical-stage company, focuses on developing gene therapies to radically transform the lives of patients with neurodegenerative diseases. It has a license agreement with Oxford BioMedica (UK) Ltd. to develop and commercialize AXO-Lenti-PD and related gene therapy products; and The University of Massachusetts Medical S...

Get notified when there are updates to the investment portfolio of Jbf Capital, Inc., based on Form 13F filings with the SEC.

Stay updated on Jbf Capital, Inc. with notifications on news.